Prophylactic treatment with Hypoxis hemerocallidea corm (African potato) methanolic extract ameliorates Brachyspira hyodysenteriae-induced murine typhlocolitis

Experimental Biology and Medicine

Volumn 235, Issue 2, 2010, Pages 222-229

  Liu, Zhiping ^a   Wilson Welder, Jennifer H ^a   Hostetter, Jesse M ^a   Jergens, Albert E ^a   Wannemuehler, Michael J ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

African potato; Brachyspira hyodysenteriae; Hypoxis hemerocallidea; Methanolic extract; NF B; Typhlocolitis

Indexed keywords

ANTIINFLAMMATORY AGENT; HYPOXIS HEMEROCALLIDEA EXTRACT; MESSENGER RNA; METHANOL; MYELOPEROXIDASE; PLANT EXTRACT; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL STRAIN; BRACHYSPIRA HYODYSENTERIAE; CELL PROLIFERATION; CONTROLLED STUDY; ENTEROPATHY; ENZYME ACTIVITY; GENE EXPRESSION; HISTOLOGY; HYPOXIS; HYPOXIS HEMEROCALLIDEA; INFECTION PREVENTION; INTESTINE EPITHELIUM; INTESTINE EPITHELIUM CELL; MOUSE; MUCOSA INFLAMMATION; NONHUMAN; POTATO; TRADITIONAL MEDICINE; TREATMENT DURATION; TYPHLOCOLITIS; WEIGHT REDUCTION;

AFRICA, SOUTHERN; ALKYNES; ANIMALS; ANTI-INFLAMMATORY AGENTS; BRACHYSPIRA HYODYSENTERIAE; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GLUCOSIDES; GRAM-NEGATIVE BACTERIAL INFECTIONS; HYPOXIS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MICE; MICE, INBRED C3H; NEUTROPHILS; NF-KAPPA B; PEROXIDASE; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA;

BRACHYSPIRA HYODYSENTERIAE; HYPOXIS HEMEROCALLIDEA; MURINAE; MUS; SOLANUM TUBEROSUM; SUIDAE;

EID: 77649118540     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2009.009269     Document Type: Article

References (42)

1. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004;126:1504-17
2. Stark R, König HH, Leidl R. Costs of inflammatory bowel disease in Germany. Pharmacoeconomics 2006;24:797-814
3. Sartor RB. Mechanisms of disease: microbial influences in inflammatory bowel diseases. Gastroenterology 2008;134:577-94
4. Eckmann L. Animal models of inflammatory bowel disease: lessons from enteric infections. Ann NY Acad Sci 2006;1072:28-38
5. Kullberg MC, Ward JM, Gorelick PL, Caspar P, Hieny S, Cheever A, Jankovic D, Sher A. Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism. Infect Immun 1998;66:5157-66
6. Hutto DL, Galvin JE, Wannemuehler MJ. Morphologic and temporal characterization of lesion in an enhanced murine model of Serpulina hyodysenteriae infection. J Med Microbiol 1998;47:275-80
7. Hutto DL, Wannemuehler MJ. A comparison of the morphologic effects of Serpulina hyodysenteriae or its beta-hemolysin on the murine cecal mucosa. Vet Pathol 1999;36:412-22
8. Jergens AE, Dorn A, Wilson J, Dingbaum K, Henderson A, Liu Z, Hostetter J, Evans RB, Wannemuehler MJ. Induction of differential immune reactivity to members of the flora of gnotobiotic mice following colonization with Helicobacter bilis or Brachyspira hyodysenteriae. Microbes Infect 2006;8:1602-10
9. Sacco RE, Hutto DL, Waters WR, Xiasong L, Kehrli ME Jr, Zuckermann FA, Wannemuehler MJ. Reduction in inflammation following blockade of CD18 or CD29 adhesive pathways during the acute phase of a spirochetal-induced colitis in mice. Microb Pathog 2000;29:289-99
10. Greer JM, Wannemuehler MJ. Pathogenesis of Treponema hyodysenteriae: induction of interleukin-1 and tumor necrosis factor by a treponemal butanol/water extract (endotoxin). Microb Pathog 1989;7:279-88
11. Sacco RE, Nibbelink SK, Baarsch MJ, Murtaugh MP, Wannemuehler MJ. Induction of interleukin (IL)-1beta and IL-8 mRNA expression in porcine macrophages by lipopolysaccharide from Serpulina hyodysenteriae. Infect Immun 1996;64:4369-72
12. Domenech E. Inflammatory bowel disease: current therapeutic options. Digestion 2006;73(Suppl. 1):67-76
13. Hendrickson BA, Gokhale R, Cho JH. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev 2002;15:79-94
14. Singh Y. Hypoxis: yellow stars of horticulture, folk remedies and conventional medicine. Veld Flora 1999;85:123-5
15. Drewes SE, Elliot E, Khan F, Dhlamini JT, Gcumisa MS. Hypoxis hemerocallidea - not merely a cure for benign prostate hyperplasia. J Ethnopharmacol 2008;119:593-8
16. Owira PM, Ojewole JA. 'African potato' (Hypoxis hemerocallidea corm): a plant-medicine for modern and 21st century diseases of mankind? - a review. Phytother Res 2009;23:147-52
17. Ojewole JA. Antinociceptive, anti-inflammatory and antidiabetic properties of Hypoxis hemerocallidea Fisch. & C.A. Mey. (Hypoxidaceae) corm ('African Potato') aqueous extract in mice and rats. J Ethnopharmacol 2006;103:126-34
18. Kruger PB, Albrecht CF, Liebenberg RW, van Jaarsveld PP. Studies on hypoxoside and rooperol analogues from Hypoxis rooperi and Hypoxis latifolia and their biotransformation in man by using high-performance liquid chromatography with in-line sorption enrichment and diode-array detection. J Chromatogr B Biomed Appl 1994;662:71-8
19. Guzdek A, Nizankowska E, Allison AC, Kruger PB, Koj A. Cytokine production in human and rat macrophages and dicatechol rooperol and esters. Biochem Pharmacol 1996;52:991-8
20. Bereta J, Bereta M, Allison AC, Kruger PB, Koj A. Inhibitory effect of di-catechol rooperol on VCAM-1 and iNOS expression in cytokinestimulated endothelium. Life Sci 1997;60:325-34
21. Guzdek A, Rokita H, Cichy J, Allison AC, Koj A. Rooperol tetraacetate decreases cytokine mRNA levels and binding capacity of transcription factors in U937 cells. Mediators Inflamm 1998;7:13-8
22. Laporta O, Funes L, Garzón MT, Villala?́n J, Micol V. Role of membranes on the antibacterial and anti-inflammatory activities of the bioactive compounds from Hypoxis rooperi corm extract. Arch Biochem Biophys 2007;467:119-31
23. Palic D, Andreasen CB, Menzel BW, Roth JA. A rapid, direct assay to measure degranulation of primary granules in neutrophils from kidney of fathead minnow (Pimephales promelas Rafinesque, 1820). Fish Shellfish Immunol 2005;19:217-27
24. Gaidamashivili M, van Staden J. Interaction of lectin-like proteins of South African medicinal plants with Staphylococcus aureus and Bacillus subtilis. J Ethnopharmacol 2002;80:131-5
25. Steenkamp V, Gouws MC, Gulumian M, Elgorashi EE, van Staden J. Studies on antibacterial, anti-inflammatory and anti-oxidant activity of herbal remedies used in the treatment of benign prostatic hyperplasia. J Ethnopharmacol 2006;103:71-5
26. Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984;87:1344-50
27. Egan LJ, Toruner M. NF-kappaB signaling: pros and cons of altering NF-kappaB as a therapeutic approach. Ann N Y Acad Sci 2006;1072:114-22
28. Perkins ND. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 2007;8:49-62
29. Neumann M, Naumann M. Beyond IkappaBs: alternative regulation of NF-kappaB activity. FASEB J 2007;21:2642-54
30. Egan LJ, Toruner M. NF-kappaB signaling: pros and cons of altering NF-kappaB as a therapeutic approach. Ann N Y Acad Sci 2006;1072:114-22
31. Hollenbach E, Neumann M, Vieth M, Roessner A, Malfertheiner P, Naumann M. Inhibition of p38 MAP kinase- and RICK/ NF-kappaB-signaling suppresses inflammatory bowel disease. FASEB J 2004;18:1550-2
32. Elson CO, Cong Y, McCracken VJ, Dimmitt RA, Lorenz RG, Weaver CT. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol Rev 2005;206:260-76
33. Ye Z, Liu Z, Henderson A, Lee K, Hostetter J, Wannemuehler M, Hendrich S. Increased CYP4B1 mRNA is associated with the inhibition of dextran sulfate sodium-induced colitis by caffeic acid in mice. Exp Biol Med 2009;234:605-16
34. Karrasch T, Kim JS, Jang BI, Jobin C. The flavonoid luteolin worsens chemical-induced colitis in NF-kappaB(EGFP) transgenic mice through blockade of NF-kappaB-dependent protective molecules. PLoS ONE 2007;2:e596
35. Joo YE, Karrasch T, Mühlbauer M, Allard B, Narula A, Herfarth HH, Jobin C. Tomato lycopene extract prevents lipopolysaccharide-induced NF-kappaB signaling but worsens dextran sulfate sodium-induced colitis in NF-kappaBEGFP mice. PLoS ONE 2009;4:e4562
36. Karrasch T, Jobin C. NF-kappaB and the intestine: friend or foe? Inflamm Bowel Dis 2008;14:114-24
37. Nair VD, Kanfer I. High-performance liquid chromatographic method for the quantitative determination of hypoxoside in African potato (Hypoxis hemerocallidea) and in commercial products containing the plant material and/or its extracts. J Agric Food Chem 2006;54:2816-21
38. Nair VD, Kanfer I. A capillary zone electrophoresis method for the quantitative determination of hypoxoside in commercial formulations of African potato (Hypoxis hemerocallidea). Phytochem Anal 2007;18:475-83
39. Smit BJ, Albrecht CF, Liebenberg RW, Kruger PB, Freestone M, Gouws L, Theron E, Bouic PJ, Etsebeth S, van Jaarsveld PP. A phase I trial of hypoxoside as an oral prodrug for cancer therapy - absence of toxicity. S Afr Med J 1995;85:865-70
40. Laporta O, Perz-fonsa L, Mallaviaa R, Caturlaa N, Micol V. Isolation, characterization and antioxidant capacity assessment of the bioactive compounds derived from Hypoxis rooperi corm extract (African potato). Food Chem 2007;101:1425-37
41. Nair VD, Dairam A, Agbonon A, Arnason JT, Foster BC, Kanfer I. Investigation of the antioxidant activity of African potato (Hypoxis hemerocallidea). J Agric Food Chem 2007;55:1707-11
42. Xu CT, Meng SY, Pan BR. Drug therapy for ulcerative colitis. World J Gastroenterol 2004;10:2311-7